Related Experiment Video
Updated: Jul 19, 2026
06:35
Cell Membrane Repair Assay Using a Two-photon Laser Microscope
Published on: January 2, 2018
Dysferlin expression in monocytes: a source of mRNA for mutation analysis
N De Luna1, A Freixas, P Gallano
1Servei de Neurologia i Laboratori de Neurologia Experimental, Hospital de la Santa Creu i Sant Pau i Institut de Recerca de HSCSP, Universitat Autònoma, Barcelona, Spain.
Neuromuscular Disorders : NMD
|October 31, 2006
Summary
Analyzing dysferlinopathy mutations is now simpler. Researchers can reliably use monocyte cDNA for mutational analysis, offering a less invasive alternative to muscle biopsies for diagnosing this genetic muscle disorder.
Area of Science:
- Genetics
- Molecular Biology
- Neuromuscular Disorders
Background:
- Dysferlin protein is crucial for muscle function and is expressed in peripheral blood monocytes.
- Genomic analysis of the DYSF gene is challenging due to its large size (55 exons).
- Current diagnostic methods for dysferlinopathy often require invasive muscle biopsies.
Purpose of the Study:
- To develop and validate a less invasive mutational screening strategy for dysferlinopathy.
- To assess the feasibility of using messenger RNA (mRNA) from monocytes for DYSF gene analysis.
- To establish monocyte cDNA as a reliable alternative to genomic DNA analysis for diagnosing dysferlinopathy.
Main Methods:
- Studied 34 patients from 23 families diagnosed with dysferlinopathy.
- Designed a mutational screening strategy using cDNA derived from peripheral blood monocytes.
- Confirmed findings using genomic DNA analysis in a subset of patients.
- Diagnosis was based on clinical findings and absence of dysferlin protein expression in muscle and/or monocytes.
Main Results:
- Identified 28 different mutations in the DYSF gene, including 13 novel mutations.
- Confirmed DYSF mutations in both alleles in 30 patients and in one allele in four patients.
- Demonstrated reliable mutational analysis using monocyte cDNA, with results confirmed by genomic DNA analysis in 26/34 patients.
Conclusions:
- Monocyte cDNA analysis provides a reliable and effective method for mutational screening in dysferlinopathy.
- This approach offers a less invasive and practical alternative to traditional muscle biopsy for genetic analysis.
- The findings support the use of monocyte-derived mRNA for diagnosing dysferlinopathies and advancing research in genetic muscle disorders.